Phillip Grote

Phillip Grote

Auto-generated profile, based on publicly available information

Phillip Grote

Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2016 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
SSSandra U. Schmitz
Sandra U. Schmitz
PGPhillip Grote
Phillip Grote
Bernhard HerrmannBernhard Herrmann
Bernhard Herrmann
Since decades it has been known that non-protein-coding RNAs have important cellular functions. Deep sequencing recently facilitated the discovery of thousands of novel transcripts, now classified as long noncoding RNAs (lncRNAs), in many vertebrate and invertebrate species. LncRNAs are involved in a wide range of cellular mechanisms, from almost all aspects of gene expression to protein translation and stability. Recent findings implicate lncRNAs as key players of cellular differentiation, cell lineage choice, organogenesis and tissue homeostasis. Moreover, lncRNAs are involved in pathological conditions such as cancer and cardiovascular disease, and therefore provide novel biomarkers and pharmaceutical targets. Here we discuss examples illustrating the versatility of lncRNAs in gene control, development and differentiation, as well as in human disease.

1 January 2013 in Developmental Cell
Verified
Journal Article
Closed access
PGPhillip Grote
Phillip Grote
LWLars Wittler
Lars Wittler
DHDavid Hendrix
David Hendrix
FKFrederic Koch
Frederic Koch
SWSandra Währisch
Sandra Währisch
Bernhard HerrmannBernhard Herrmann
Bernhard Herrmann

1 February 2005 in Nature
Verified
Journal Article
Closed access
PDF file
RJRavi Jagasia
Ravi Jagasia
PGPhillip Grote
Phillip Grote
BWBenedikt Westermann
Benedikt Westermann
BCBarbara Conradt
Barbara Conradt

23 October 2020 in eLife
Verified
Journal Article
Open access
TATamer Ali
Tamer Ali
PGPhillip Grote
Phillip Grote
While long non-coding RNA (lncRNA) genes have attracted a lot of attention in the last decade, the focus regarding their mechanisms of action has been primarily on the RNA product of these genes. Recent work on several lncRNAs genes demonstrates that not only is the produced RNA species important, but also that transcription of the lncRNA locus alone can have regulatory functions. Like the functions of lncRNA transcripts, the mechanisms that underlie these genome-based functions are varied. Here we highlight some of these examples and provide an outlook on how the functional mechanisms of a lncRNA gene can be determined.

1 September 2017 in Developmental Cell
Verified
Journal Article
Closed access
FKFrederic Koch
Frederic Koch
MSManuela Scholze
Manuela Scholze
LWLars Wittler
Lars Wittler
DSDennis Schifferl
Dennis Schifferl
SSSmita Sudheer
Smita Sudheer
Bernhard HerrmannBernhard Herrmann
Bernhard Herrmann

16 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
PNPhilipp Neumann
Philipp Neumann
NJNicolas Jaé
Nicolas Jaé
AKAndrea Knau
Andrea Knau
SGSimone-Franziska Glaser
Simone-Franziska Glaser
YFYoussef Fouani
Youssef Fouani
DBDittmar Böckler
Dittmar Böckler
Impaired or excessive growth of endothelial cells contributes to several diseases. However, the functional involvement of regulatory long non-coding RNAs in these processes is not well defined. Here, we show that the long non-coding antisense transcript of GATA6 (GATA6-AS) interacts with the epigenetic regulator LOXL2 to regulate endothelial gene expression via changes in histone methylation. Using RNA deep sequencing, we find that GATA6-AS is upregulated in endothelial cells during hypoxia. Silencing of GATA6-AS diminishes TGF-β2-induced endothelial–mesenchymal transition in vitro and promotes formation of blood vessels in mice. We identify LOXL2, known to remove activating H3K4me3 chromatin marks, as a GATA6-AS-associated protein, and reveal a set of angiogenesis-related genes that are inversely regulated by LOXL2 and GATA6-AS silencing. As GATA6-AS silencing reduces H3K4me3 methylation of two of these genes, periostin and cyclooxygenase-2, we conclude that GATA6-AS acts as negative regulator of nuclear LOXL2 function.